Types of Immune Cells and What They Do

Neutrophils: The First Responders

Neutrophils are the most abundant white blood cells in human blood, making up 50 to 70 percent of all circulating leukocytes. An adult produces roughly 100 billion neutrophils per day in the bone marrow, maintaining a circulating pool that can be rapidly mobilized to sites of infection. Neutrophils are the immune system's shock troops, arriving at a wound or infection site within 30 to 60 minutes, often ahead of any other immune cell.

Neutrophils kill pathogens through three primary mechanisms. Phagocytosis involves engulfing the pathogen in a membrane-bound vesicle called a phagosome, which fuses with lysosomes containing digestive enzymes and reactive oxygen species. Degranulation releases preformed antimicrobial proteins and enzymes directly into the surrounding tissue. NETosis involves the neutrophil extruding its own DNA in a web-like structure called a neutrophil extracellular trap (NET), which ensnares bacteria and exposes them to concentrated antimicrobial molecules. NETosis kills the neutrophil in the process, making it a form of programmed cell death in service of defense.

Neutrophils are short-lived cells, surviving only 1 to 5 days in the bloodstream before undergoing apoptosis and being cleared by macrophages. This rapid turnover is why neutrophil counts in the blood can swing dramatically during infection: the bone marrow ramps up production in response to inflammatory signals, sometimes doubling or tripling the circulating neutrophil count within hours. Pus, the yellowish fluid that accumulates at infection sites, consists largely of dead neutrophils, killed bacteria, and tissue debris.

Macrophages: The Versatile Sentinels

Macrophages are large phagocytic cells that reside in virtually every tissue of the body, acting as sentinel immune cells that detect and respond to threats in real time. Unlike neutrophils, which are recruited from the bloodstream during active infection, macrophages are already stationed throughout the tissues, positioned to intercept pathogens at the earliest possible moment. Tissue-resident macrophages carry specialized names: Kupffer cells in the liver, alveolar macrophages in the lungs, microglia in the brain, osteoclasts in bone, and Langerhans cells in the skin.

Macrophages perform far more functions than simple phagocytosis. They produce cytokines and chemokines that initiate inflammation and recruit other immune cells. They present antigens on MHC class II molecules, helping to activate T cells and bridge innate and adaptive immunity. They clear dead cells and cellular debris through a process called efferocytosis, which is essential for tissue homeostasis and wound healing. They remodel the extracellular matrix during tissue repair. In chronic infections, macrophages can fuse together to form multinucleated giant cells that wall off pathogens the immune system cannot eliminate, a process seen in tuberculosis and certain fungal infections.

Macrophages exist along a spectrum of activation states. Classically activated (M1) macrophages are pro-inflammatory, specialized for killing intracellular pathogens and promoting Th1 immune responses. Alternatively activated (M2) macrophages are anti-inflammatory, focused on tissue repair, fibrosis, and parasite defense. In reality, macrophage polarization is more of a continuum than a binary switch, with individual cells shifting their functional profile in response to changing signals in their environment.

Dendritic Cells: The Messengers

Dendritic cells (DCs) are the professional antigen-presenting cells of the immune system and the critical link between innate and adaptive immunity. Named for their tree-like branching projections (dendrites), these cells reside in peripheral tissues such as the skin, mucosal surfaces, and the lining of the gut, where they continuously sample the environment for signs of infection.

When a dendritic cell captures a pathogen, either through phagocytosis, macropinocytosis, or receptor-mediated endocytosis, it processes the pathogen's proteins into small peptide fragments and loads them onto MHC class I and MHC class II molecules. The dendritic cell then undergoes maturation, upregulating co-stimulatory molecules on its surface and migrating through lymphatic vessels to the nearest draining lymph node. There, it presents its antigen-MHC complexes to circulating T cells. If a T cell's receptor recognizes the presented peptide with sufficient affinity, and receives the co-stimulatory signals provided by the mature dendritic cell, that T cell becomes activated.

Dendritic cells are the only cell type capable of activating naive T cells, meaning T cells that have never encountered their target antigen before. This makes dendritic cells the indispensable initiators of all primary adaptive immune responses. Immature dendritic cells that present self-antigens without co-stimulation can also induce T cell tolerance, helping to prevent autoimmune responses. This dual role as both activator and tolerizer gives dendritic cells a central position in immune regulation.

T Cells: The Commanders and Killers

T lymphocytes, or T cells, are the central coordinators and effectors of adaptive cellular immunity. All T cells develop from bone marrow precursors that migrate to the thymus, where they undergo a rigorous selection process lasting about 3 weeks. During this process, T cells that react too strongly to the body's own proteins are eliminated (negative selection), while T cells that can interact productively with MHC molecules are preserved (positive selection). Only about 2 percent of T cell precursors survive thymic selection; the rest die by apoptosis.

CD4+ helper T cells are the coordinators of the immune response. They do not kill pathogens directly but instead release cytokines that activate and direct other immune cells. Th1 cells produce interferon-gamma (IFN-gamma) and activate macrophages for intracellular killing, making them essential for defense against bacteria, viruses, and protozoa that hide inside host cells. Th2 cells produce interleukins 4, 5, and 13, driving B cell antibody class switching to IgE and activating eosinophils, making them critical for defense against parasitic worms and also central to allergic disease. Th17 cells produce interleukin-17, which recruits neutrophils and is important for defense against extracellular bacteria and fungi, particularly at mucosal surfaces. Follicular helper T cells (Tfh) reside in lymph node germinal centers, where they provide the signals B cells need to undergo affinity maturation and produce high-quality antibodies.

CD8+ cytotoxic T lymphocytes (CTLs) are the killers of the adaptive immune system. They recognize pathogen-derived peptides displayed on MHC class I molecules, which are present on virtually every nucleated cell in the body. When a CTL's receptor matches a peptide-MHC I complex on an infected cell, the CTL releases perforin, a protein that forms pores in the target cell's membrane, and granzymes, serine proteases that enter through the pores and trigger apoptosis. This mechanism allows CTLs to kill virus-infected cells with precision, eliminating the cell before it can produce more virus, while leaving neighboring uninfected cells intact.

Regulatory T cells (Tregs) express the transcription factor FoxP3 and specialize in suppressing immune responses. They prevent autoimmunity by restraining T cells that might otherwise attack the body's own tissues. They dampen inflammation after an infection has been cleared, allowing tissues to heal. They also maintain immune tolerance to commensal bacteria in the gut and to the fetus during pregnancy. Defects in Treg function are associated with severe autoimmune disease, chronic inflammation, and transplant rejection.

B Cells: The Antibody Factories

B lymphocytes, or B cells, are the producers of antibodies and the effectors of humoral immunity. Each B cell carries approximately 100,000 copies of its unique B cell receptor (BCR) on its surface, which is essentially a membrane-bound form of the antibody it will eventually secrete. When a B cell encounters its specific antigen, it internalizes the antigen-BCR complex, processes the antigen, and presents peptide fragments on MHC class II molecules to helper T cells. The helper T cell signals, delivered through direct contact and cytokine secretion, trigger the B cell to proliferate and differentiate.

Activated B cells can differentiate along two paths. Plasma cells are antibody-secreting factories, each capable of producing approximately 2,000 antibody molecules per second. Short-lived plasma cells die within a few days, providing a burst of antibodies during the acute phase of an immune response. Long-lived plasma cells migrate to the bone marrow, where they can continue secreting antibodies for years or even a lifetime, maintaining baseline antibody levels that provide ongoing protection against previously encountered pathogens.

Memory B cells represent the second differentiation path. These cells do not secrete antibodies but persist in the body in a quiescent state, circulating through the blood and lymphoid tissues. Upon re-encounter with their specific antigen, memory B cells activate rapidly and differentiate into plasma cells and more memory cells, producing a secondary immune response that is faster, stronger, and generates higher-affinity antibodies than the primary response. Memory B cells are the cellular basis of long-term vaccine-induced immunity.

Natural Killer Cells: Innate Lymphocytes

Natural killer (NK) cells are large granular lymphocytes that belong to the innate immune system. Unlike T cells and B cells, NK cells do not express antigen-specific receptors generated by V(D)J recombination. Instead, they use a set of germline-encoded activating and inhibitory receptors to assess whether a cell should be killed. The key inhibitory signal comes from MHC class I molecules: healthy cells display MHC class I on their surface, which engages inhibitory receptors on NK cells and prevents killing. Virus-infected cells and tumor cells often downregulate MHC class I to evade detection by cytotoxic T cells, but this loss of MHC class I removes the inhibitory signal for NK cells, activating them to kill.

NK cells kill targets using the same perforin and granzyme mechanism employed by cytotoxic T cells. They are also major producers of interferon-gamma, a cytokine that activates macrophages and promotes Th1 adaptive responses. NK cells can detect and kill target cells within hours, making them an important early defense against viral infections and emerging tumors, buying time for the slower adaptive response to develop. They also participate in antibody-dependent cellular cytotoxicity (ADCC), killing antibody-coated target cells through their Fc receptors, which represents another point of integration between innate and adaptive immunity.

Mast Cells, Basophils, and Eosinophils

Mast cells are tissue-resident immune cells found primarily in connective tissues near blood vessels, nerves, and mucosal surfaces. They are loaded with granules containing histamine, heparin, proteases, and cytokines. When IgE antibodies bound to mast cell surface receptors are cross-linked by an allergen, the mast cell degranulates explosively, releasing its contents into the surrounding tissue. This produces the redness, swelling, itching, and smooth muscle contraction that characterize allergic reactions. Mast cells also play protective roles in defense against parasites, wound healing, and vascular regulation.

Basophils are the least abundant white blood cells, constituting less than 1 percent of circulating leukocytes. They share some functional similarities with mast cells, including IgE-mediated degranulation and histamine release, but they circulate in the blood rather than residing in tissues. Basophils are important in Th2 immune responses and appear to play roles in anti-parasitic immunity and the regulation of allergic inflammation.

Eosinophils are specialized for defense against multicellular parasites, particularly helminths (parasitic worms). They contain cytoplasmic granules loaded with major basic protein, eosinophil cationic protein, eosinophil peroxidase, and eosinophil-derived neurotoxin, all of which are toxic to parasites. When activated, eosinophils release these granule proteins onto the surface of parasites too large to be phagocytosed, damaging their outer layers. Eosinophils are also recruited to sites of allergic inflammation, where their granule proteins contribute to tissue damage in conditions like asthma and eosinophilic esophagitis.